ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 1 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,122 | +18.2% | 37,039 | +46.9% | 0.00% | – |
| Q2 2023 | $170,170 | -59.6% | 25,222 | -47.3% | 0.00% | -100.0% |
| Q1 2023 | $420,936 | +19.1% | 47,827 | +0.5% | 0.00% | – |
| Q4 2022 | $353,299 | -3.5% | 47,587 | -5.0% | 0.00% | -100.0% |
| Q3 2022 | $366,000 | +2.2% | 50,097 | +10.7% | 0.00% | – |
| Q2 2022 | $358,000 | -12.9% | 45,275 | +54.2% | 0.00% | – |
| Q1 2022 | $411,000 | -18.0% | 29,356 | +138.9% | 0.00% | -100.0% |
| Q2 2021 | $501,000 | +128.8% | 12,290 | +126.3% | 0.00% | – |
| Q1 2021 | $219,000 | -42.2% | 5,430 | -15.4% | 0.00% | -100.0% |
| Q4 2020 | $379,000 | -2.3% | 6,415 | -20.0% | 0.00% | 0.0% |
| Q3 2020 | $388,000 | – | 8,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
| Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
| VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
| Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
| Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
| Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
| Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
| Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
| PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |